11 – 20 of 21
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2021
-
Targeting Alveolar Repair in Idiopathic Pulmonary Fibrosis
(2021)
In American Journal of Respiratory Cell and Molecular Biology
65(4).
p.347-347
- Contribution to journal › Article
- 2020
-
Lung regeneration : implications of the diseased niche and ageing
(2020)
In European Respiratory Review
29(157).
- Contribution to journal › Article
-
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019
(2020)
In ERJ Open Research
6(4).
- Contribution to journal › Scientific review
- 2019
-
Extracellular and intracellular small-molecule galectin-3 inhibitors
(2019)
In Scientific Reports
9(1).
- Contribution to journal › Article
-
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
(2019)
In Acta Neuropathologica
138(2).
p.251-273
- Contribution to journal › Article
- 2018
-
The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin
(2018)
In ACS Central Science
4(6).
p.760-767
- Contribution to journal › Article
-
Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin–glycan specificities in a natural context
(2018)
In Journal of Biological Chemistry
293(52).
p.20249-20262
- Contribution to journal › Article
- 2017
-
Galectin Inhibitors – Molecular Tools in Biomedical Research and Clinical Implications
(2017)
- Thesis › Doctoral thesis (compilation)
- 2016
-
Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition
(2016)
In ChemBioChem
17(18).
p.1759-1770
- Contribution to journal › Article
-
Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans
(2016)
In Journal of Biological Chemistry
291(25).
p.13318-13334
- Contribution to journal › Article